Gene Therapy : Impact Factor & More
eISSN: 1476-5462pISSN: 0969-7128
Share this on:
Key Metrics
CiteScore 
7.6
H-Index
169
Impact Factor
5 - 10
SJR
Q1Genetics
SNIP
0.82
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Gene Therapy
Gene Therapy Journal Specifications
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Gene Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Gene Therapy
Real-world experience with gene therapy in Duchenne muscular dystrophy center readiness and patients safety: report from Qatar.
- 27 Nov 2025
- Gene therapy
Ad astra per aspera: treatment challenges and opportunities for children with spinal muscular atrophy and tracheostomy.
- 25 Nov 2025
- Gene therapy
Multi-targeting zinc finger nuclease vector unsilences paternal UBE3A in a mouse model of Angelman syndrome.
- 25 Nov 2025
- Gene therapy
Codon-optimized human Smad7 gene therapy enhances skeletal muscle mass and function in a murine model of Duchenne muscular dystrophy.
- 25 Nov 2025
- Gene therapy
Correction: Anti-inflammatory effect of MAPK phosphatase-1 local gene transfer in inflammatory bone loss.
- 24 Nov 2025
- Gene therapy
Murine toxicology assessment of avgn7.2, a novel gene therapeutic for inclusion body myositis and other muscle wasting diseases.
- 19 Nov 2025
- Gene therapy
Real-world experience with gene therapy in Duchenne muscular dystrophy center readiness and patients safety: report from Qatar.
- 27 Nov 2025
- Gene therapy
Ad astra per aspera: treatment challenges and opportunities for children with spinal muscular atrophy and tracheostomy.
- 25 Nov 2025
- Gene therapy
Multi-targeting zinc finger nuclease vector unsilences paternal UBE3A in a mouse model of Angelman syndrome.
- 25 Nov 2025
- Gene therapy
Codon-optimized human Smad7 gene therapy enhances skeletal muscle mass and function in a murine model of Duchenne muscular dystrophy.
- 25 Nov 2025
- Gene therapy
Correction: Anti-inflammatory effect of MAPK phosphatase-1 local gene transfer in inflammatory bone loss.
- 24 Nov 2025
- Gene therapy
Murine toxicology assessment of avgn7.2, a novel gene therapeutic for inclusion body myositis and other muscle wasting diseases.
- 19 Nov 2025
- Gene therapy
FAQs on Gene Therapy
How long has Gene Therapy been actively publishing? 
What is the publishing frequency of Gene Therapy?
How many articles did Gene Therapy publish last year?
What is the eISSN & pISSN for Gene Therapy?
What is Citescore for Gene Therapy?
What is the H Index for Gene Therapy ?
What is SNIP score for Gene Therapy?
What is the SJR for Gene Therapy?
Who is the publisher of Gene Therapy?
